Unusual adverse dermatologic conditions associated with fingolimod and natalizumab in a patient with relapsing remitting multiple sclerosis

Authors

Loulwah Mukharesh, Johns Hopkins School of Medicine
Heidi Maloni, The George Washington University
Mary Maiberger, VA Medical Center
Wen Chen, VA Medical Center
Mitchell Wallin, The George Washington University

Document Type

Journal Article

Publication Date

8-1-2020

Journal

Clinical Neurology and Neurosurgery

Volume

195

DOI

10.1016/j.clineuro.2020.105886

Keywords

Fingolimod; Leukocytoclastic vasculitis (LCV); Multiple sclerosis; Natalizumab; Pityriasis lichenoides et varioliformis acute (PLEVA)

APA Citation

Mukharesh, L., Maloni, H., Maiberger, M., Chen, W., & Wallin, M. (2020). Unusual adverse dermatologic conditions associated with fingolimod and natalizumab in a patient with relapsing remitting multiple sclerosis. Clinical Neurology and Neurosurgery, 195 (). http://dx.doi.org/10.1016/j.clineuro.2020.105886